A B S T R A C T Previous studies in vivo and with isolated perfused rat livers have suggested that the deleterious effect of ethanol on hepatic pyridoxal 5'-phosphate metabolism is mediated by acetaldehyde. Inasmuch as acetaldehyde has no effect on the synthesis of pyridoxal phosphate, it has also been postulated that acetaldehyde accelerates pyridoxal phosphate degradation by displacing this coenzyme from binding proteins, which protect it against hydrolysis. To test these hypotheses, studies have been performed with isolated rat hepatocytes, subcellular fractions of rat liver, and human erythrocytes. Ethanol oxidation lowered the pyridoxal phosphate content of isolated liver cells when acetaldehyde oxidation was inhibited by either disulfiram or prior treatment of rats with cyanamide. Additions of 7.5 mM acetaldehyde alone at 40-min intervals to cell suspensions decreased hepatic pyridoxal phosphate content only slightly because acetaldehyde was rapidly metabolized. However, when acetaldehyde oxidation and reduction were inhibited by cyanamide treatment and by 4-methylpyrazole and isobutyramide, respectively, a 40% decrease in hepatic pyridoxal phosphate content was observed in 80 min of incubation.
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In equilibrium dialysis experiments, acetaldehyde, 7.5 and 15 mM, displaced protein-bound pyridoxal phosphate in undialyzed hepatic cytosol and in hemolysate supernate containing added pyridoxal phosphate. In the presence of alkaline phosphatase, acetaldehyde accelerated the degradation of pyridoxal phosphate in dialyzed hemolysate supernate and hepatic cytosol with added pyridoxal phosphate. Acetaldehyde also inhibits tyrosine aminotransferase. The kinetics of inhibition were mixed competitive-noncompeti-INTRODUCTION Vitamin B6 deficiency, as evidenced by a decreased level of plasma pyridoxal 5'-phosphate (PLP),l is frequently encountered in alcoholic patients both with (1, 2) and without (3) liver disease. Although inadequate dietary intake may be a contributory factor, it has been shown that alcohol ingestion interferes with the net conversion of parenterally administered pyridoxine to plasma PLP (1) . In experimental animals, PLP in plasma is derived almost entirely from liver, and its concentration is determined both by hepatic synthesis and by degradation (4) . We have reported that the oxidation of alcohol by isolated perfused rat livers curtails both the release of PLP into the perfusion medium and lowers hepatic PLP content (5) . These deleterious effects of alcohol on PLP metabolism are abolished by 4-methylpyrazole, a specific inhibitor of alcohol dehydrogenase, suggesting that acetaldehyde may be the causative agent (5) . Indeed, incubation of human erythrocytes with 0.05-1 mM acetaldehyde impairs the net conversion of pyridoxine to PLP (3) . Because acetaldehyde does not alter the rate of PLP synthesis (3), it was postulated that acetaldehyde accelerates PLP degradation.
In the normal regulation of vitamin B6 metabolism in liver, the cellular content of PLP is governed principally by protein binding on the one hand and by hydrolysis of unbound (free) PLP by alkaline phosphatase on the other (6) . Because acetaldehyde, like PLP, is capable of forming Schiff's bases with protein amino groups, it was postulated that acetaldehyde accelerates PLP degradation by displacing PLP from protein binding. This hypothesis has now been tested in experiments with isolated rat hepatocytes, subcellular fractions of rat liver, and human erythrocytes. The efficacy of acetaldehyde in displacing PLP from protein binding of PLP has also been directly measured.
METHODS
Preparation of isolated rat hepatocytes. Male SpragueDawley rats (150-250 g), maintained for at least 1 wk on standard laboratory chow (Wayne Lab-Blox; Allied Mills, Inc., Chicago, Ill.) ad lib., were fasted 12-18 h before use for the isolation of liver parenchymal cells. The pyridoxine content of the diet was 8.1 ,ug/g. In some experiments, rats were injected intraperitoneally with cyanamide, 0.1 mg/kg, 1 h before the preparation of isolated liver cells (7) . The method for isolating liver cells was similar to the procedure described by Seglen (8) . The major steps included the addition of 2.5 mM CaCl2 to the Hanks' medium during collagenase digestion and the further dispersion ofthe minced liver with hyaluronidase (8 mg/50 ml of medium) after perfusion with collagenase. The isolated parenchymal cells were >98% pure. 90-95% of the liver cells excluded trypan blue and exhibited intracellular K+ concentration of 134±+ 10.5 meq/liter (n = 10). The cells were morphologically intact by electron microscopy (9) and were active in amino acid transport (10), gluconeogenesis (10) , and synthesis of enzymes inducible by hormones (11) . These measures of viability were maintained with little change for at least 4 h after isolation.
Preparation of supernate and membrane fractions of human erythrocytes. Venous blood was collected from healthy human volunteers with 2 mM EDTA as an anticoagulant. After separation from plasma and buffy coat, the erythrocytes were washed twice with 0.15 M NaCl at 4°C, and hemolyzed by either hypotonic lysis or freeze-thaw. In the former procedure, the washed erythrocytes were hemolyzed with 10 vol of 12 mM triethanolamine hydrochloride (TEA-HCI), pH 7.4, at 4°C. After 10 min of intermittent mixing, the hemolysate was centrifuged at 30,000 g for 30 min to separate the supernatant fraction from the erythrocyte membranes. To prepare hemolysate by freeze-thaw, the washed erythrocytes were quick-frozen in an acetone-dry ice bath and thawed four times. The membrane ghosts were then separated by centrifugation at 100,000 g for 90 min. For studies that required recombination of supernate and membrane fractions, the membrane fraction derived from hypotonic lysis of erythrocytes was washed six or more times with the TEA-HCI buffer until the erythrocyte membranes became colorless. Before recombination, the hemolysate supernate was dialyzed extensively in 12 mM TEA-HCI buffer and the membrane ghosts were disrupted by sonication, employing a model 1,000 Insonator (Savant Instruments, Inc., Hicksville, N. Y.) (20 kHz) supplied with a half-inch sonohorn. The reference meter setting was 75, and sonication was applied three times in 10-s pulses at 4°C.
Preparation of cytosolic fraction and isolated plasma membranes from rat liver. Male Sprague-Dawley rats (150-250 g), fasted 12-18 h, were used for the preparation of subcellular fractions. Cytosolic fraction and plasma membranes were prepared by the methods of Hogeboom (12) and of Ray (13) , respectively.
Purification of tyrosine aminotransferase. Tyrosine aminotransferase was purified from rat liver as described by Granner and Tomkins (14) . The procedure was carried out through the DEAE-cellulose chromatography step; at which point, the yield was 18-25% and the specific activity of the enzyme was 72-95 U/mg protein. Tyrosine aminotransferase was resolved of its coenzyme (PLP) by dialysis for 18 h at 4°C against 0.1 M potassium phosphate, pH 6.0 (15) .
Incubation conditions. All incubations were performed in Erlenmeyer flasks in a shaking water bath. The experiments were conducted in darkened rooms equipped with yellow fluorescent lights to minimize photodecomposition of PLP.
In the cell experiments, freshly isolated liver cells, 15-20 mg protein/ml, were incubated at 37°C in 7.5 ml KrebsHenseleit medium containing 10 mM pyruvate and 2.5 g/100 ml fatty acid free bovine serum albumin. The incubation flasks, sealed by rubber caps, were flushed with 95% 02 and 5% CO2 before adding ethanol or acetaldehyde. In the experiments with acetaldehyde, it was necessary to add acetaldehyde at 40-min intervals because it was metabolized rapidly even when the cells were isolated from cyanamide-treated rats and incubated in the presence of 4-methylpyrazole and isobutyramide. The addition of reagents and the sampling of cell suspensions were carried out with Hamilton syringes (Hamilton Co., Reno, Nev.). At appropriate time intervals, 1-ml aliquots of cell suspension were removed and centrifuged for 3 min at 1,000 g in a Sero-Fuge (Clay Adams, Div. of Becton, Dickinson & Co., Parsippany, N. J.) to separate the cells from the medium. The medium was immediately deproteinated by adding 0.2 ml 60% HCIO4 and used for acetaldehyde assay. The cell pellet was washed with 10 vol of a cold Krebs-Henseleit medium and resuspended in 4 ml of a cold 2 mM phosphate buffer (pH 7.4). The resuspended cells, 0.2-ml aliquots, were then added to 2.5 ml 2 mM phosphate buffer (pH 7.4) and immediately precipitated with 0.3 ml 75% trichloroacetic acid. After discarding the protein precipitate, the supernate was extracted with ether and then assayed for PLP.
Anialyses. PLP and acetaldehyde were assayed enzymatically with tyrosine apodecarboxylase and aldehyde dehydrogenase, respectively (3, 16) . Hemoglobin was determined as cyanmethemoglobin (17) . Protein concentrations were measured by the method of Lowry et al. (18) .
During the purification of hepatic tyrosine aminotransferase, enzyme activity was assayed by measuring the rate of formation of p-hydroxybenzaldehyde at 37°C (19) . The final reaction mixture contained 2.4 ml of 0.125 M potassium phosphate (pH 7.6) and 7 mM L-tyrosine, 0.06 ml of 0.5 M aketoglutarate, 0.03 ml of 5 mM PLP, and 0.3 ml of tyrosine aminotransferase. The latter was diluted in a buffer that contained 0.125 M potassium phosphate (pH 7.6), 5 mg/ml bovine serum albumin, 1 mM EDTA, and 1 mM dithiothreitol. The reaction was started by the addition of enzyme, and stopped at 2.5 and 5 min by the addition of 0.21 ml of 10 N KOH. The final mixture, kept for 30 min at 37°C, was then read at 331 nm against a "zero time" blank prepared by the addition of KOH to the reaction components before tyrosine aminotransferase. The molar absorbancy of the product, phydroxybenzaldehyde, is 19,900/M cm. 1 U of enzyme activity is the quantity that catalyzes the formation of 1 ,umol p-hydroxyphenylpyruvate/min.
In the course of this work, it was found that acetaldehyde interfered with this assay method. Thus an alternative method, the modified Briggs assay (20), was employed when acetaldehyde was present in the reaction mixture. The assay condition was as described above but the reactions were terminated by adding 0.21 ml of 50% trichloroacetic acid. To this solution,
1.8 ml of water, 1 ml of 1 g/100 ml KH2PO4, and 1 ml of molybdate solution containing 5 g/100 ml ammonium molybdate in 5 N H2SO4 were added. The final mixture was allowed to stand at room temperature for 1 h and then centrifuged to remove any precipitate. The blue color of the molybdate complex was read at 850 nm with a molar absorbancy of 4,100/M cm. The Briggs assay, although less sensitive, agreed well with the assay based on p-hydroxybenzaldehyde measurement. Equilibrium dialysis. These studies were carried out in dialysis tubings with a molecular weight exclusion limit of 10,000-20,000. Dialysis was performed at 4°C in stoppered flasks to prevent evaporation of acetaldehyde. Photodecomposition of PLP was minimized by wrapping the flasks in aluminum foil.
Reagents. Cyanamide, disulfiram, isobutyramide, essentially fatty acid-free bovine albumin, PLP, aldehyde dehydrogenase, and tyrosine apodecarboxylase were purchased from Sigma Chemical Co., St. Louis, Mo. 4 The effect of acetaldehyde on PLP content of isolated liver cells prepared from untreated and cyanamide-treated rats is shown in Fig. 2 . With cells isolated from untreated animals, the addition of 7.5 mM acetaldehyde at 40-min intervals lowered the cellular content of PLP only slightly (mean decrease was 13% at the end of2-h incubation, n = 4, P < 0.01). However, acetaldehyde was metabolized rapidly and its concentration decreased to 0-0.1 mM at the end of each 40-min period. Acetaldehyde can be metabolized both by way of reduction to ethanol, catalyzed by alcohol dehydrogenase, and by way of oxidation to acetate catalyzed by aldehyde dehydrogenase. When the cells from untreated animals were incubated in the presence of isobutyramide and 4-methylpyrazole, potent inhibitors of alcohol dehydrogenase, the concentrations of acetaldehyde were 0.2-0.4 mM at the end of each 40-min period and the decrease in cellular PLP was accordingly greater (mean decrease was 22% at the end of2-h incubation, n = 4, P < 0.001). When these inhibitors were added to cells prepared from cyanamidetreated rats, the acetaldehyde concentrations were maintained in the range of 2.8-7.5 mM and cellular PLP decreased >40% (Fig. 2 , n = 4, P < 0.001). These data, therefore, indicate that under appropriate conditions, both ethanol and acetaldehyde can significantly alter the metabolism of PLP in the isolated liver cell.
Effect of acetaldehyde on protein-bound PLP in the soluble fractions of liver and erythrocytes. In liver, PLP is bound to a large number of PLP-dependent enzymes (21) . Fig. 3 shows the effect of acetaldehyde on PLP binding by hepatic cytosol as studied by equilibrium dialysis. After dialysis for 24 h, fully 20% of the cytosolic PLP, presumably free or loosely associated with proteins, was removed by dialysis in the absence of acetaldehyde. In the presence of 7.5 and 15 mM acetaldehyde, both the rate and amount of PLP removal by dialysis were increased. Fig. 4 graded by the plasma membranes of erythrocytes and liver cells (3, 6) . This PLP-hydrolyzing activity in hepatic plasma membranes has been characterized and shown to be a property of the nonspecific alkaline phosphatase enzyme which is associated with plasma membranes (22) . Additionally, it has been shown that the binding of PLP to proteins protects it from degradation by alkaline phosphatase (6) . Fig. 5 shows the effect of acetaldehyde (15 mM) on the hydrolysis of PLP in a reconstituted system of dialyzed hemolysate supernate and sonicated membrane ghosts. The amount of PLP present in dialyzed hemolysate supernate is small. This amount is tightly bound, and the addition of erythrocyte ghosts resulted in little or no change in PLP concentration after 80 min of incubation. As expected, acetaldehyde enhanced the degradation of this tightly bound PLP to only a slight extent. However, when PLP was added in vitro to the dialyzed hemolysate supemate to provide binding to low affinity sites, PLP hydrolysis by the membrane ghosts occurred more rapidly. Acetaldehyde, 10 mM, further accelerated this degradation rate and about 30 Effect of acetaldehyde on hepatic tyrosine aminotransferase. Tyrosine aminotransferase has a relatively low affinity for PLP (15) . Additionally, the relative contributions of the various functional groups of PLP to the formation ofthe coenzyme-apoenzyme complex is known (23) . Hence the effect of acetaldehyde on the activity of this enzyme was examined. Purified tyrosine aminotransferase activity was inhibited 50% by 17 .5 mM acetaldehyde. The kinetics of inhibition was mixed competitive-noncompetitive with respect to PLP (Fig. 6 ).
DISCUSSION
We have previously reported that ethanol oxidation decreases the hepatic content of PLP in isolated perfused rat livers (5) . In the present study with isolated hepatocytes, ethanol oxidation has no demonstrable effect on cellular PLP content unless acetaldehyde oxidation was inhibited concomitantly (Fig. 1) . These findings suggest that the perfused liver and isolated hepatocyte systems differ quantitatively in their ability to metabolize acetaldehyde. Data from the literature seem to support this conclusion. Thus, Crow et al. (24) have recently measured the accumulation of acetaldehyde in cell suspensions during ethanol oxidation and found its concentration to be low, in the range of 2 ,uM, but increasing to 50-180 ,uM when 0.1 mM disulfiram was added. On the other hand, Lindros et al. (25) have reported that the acetaldehyde level of isolated perfused rat livers was 150 ,uM when the ethanol concentration in the perfusates was in the range of [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] mM. Importantly, the acetaldehyde concentrations of liver have been well demonstrated to be about 200 uM in vivo during ethanol oxidation (26) . The reason for these differences is unknown but is under investigation in our laboratory.
As would be expected from the above considerations, the addition of acetaldehyde to suspension of isolated hepatocytes from untreated rats resulted in only a small decrease in cellular PLP (Fig. 2) , because acetaldehyde was rapidly metabolized by way of alcohol and aldehyde dehydrogenase in the isolated hepatocytes. The addition of 4-methylpyrazole and isobutyramide to the incubation of medium together with the use of cyan- 290 amide-treated animals progressively increased the depletion of cellular PLP so that a 40% decrease was seen when acetaldehyde concentration was maintained in the range of 2.8-7.5 mM (Fig. 2) . These data support our previous hypothesis that acetaldehyde may be the toxic metabolite responsible for the detrimental effect of ethanol oxidation of PLP metabolism (3) . The studies with subcellular fractions of human erythrocytes and rat liver (Figs. 3 and 4) (Fig. 3) .
Recent studies in our laboratories indicate that the distribution of PLP in liver is dispersed among many enzymes (21) . Glycogen phosphorylase, aspartate aminotransferase, and alanine aminotransferase in combination account for <30% of the PLP bound in liver cytosol. The identity of the PLP-enzymes and proteins responsible for the binding of the remainder ofthe PLP in cytosol remains unknown. This multiplicity of PLP-binding proteins in liver renders difficult the precise identification of the enzyme(s) most susceptible to the effect of acetaldehyde.
PLP binds to its apoenzymes by multipoint attachments (27 (26) . Acetaldehyde level in the tail blood of rats is usually <20 ,uM but the level in arterial blood may attain concentrations up to 150 AM (32) . It is also known that after disulfiram or pyrogallol treatment (33, 34) , venous blood acetaldehyde concentrations may reach levels as high as 2 mM. We have shown previously that acetaldehyde in the range of 0.05-1 mM significantly inhibits the net conversion of PLP from pyridoxal or pyridoxine in erythrocytes which do not have the capacity to metabolize acetaldehyde (3) . In the isolated hepatocyte experiments reported here, the presence of acetaldehyde at 0.1-0.4 mM and 2.8-7.5 mM resulted in 13-22% and >40% decrease in cellular PLP, respectively (Fig. 2) . Whereas the lower levels of acetaldehyde (<0.3 mM) are attainable in vivo in rat liver after acute ethanol administration, the higher levels (_2 mM) can be reached only with simultaneous disulfiram or pyrogallol treatment. In the experiments with broken cell preparations, higher concentrations (>7.5 mM) of acetaldehyde were required to consistently elicit displacement of PLP and enhancement of PLP degradation. The reason for this is unclear, but it should be emphasized that in many reports of experiments in vitro (35) (36) (37) , high concentrations of acetaldehyde approaching or in excess of 1 mM are required to demonstrate its toxic potentials. It is difficult to reconstruct in vitro with cell-free system the situation in vivo, because the exposure to acetaldehyde in man is chronic. Chronic ethanol consumption also results in higher blood acetaldehyde level due to imbalance between acetaldehyde production and disposition (38) .
The decrease of PLP content in isolated hepatocytes due to low levels of acetaldehyde (0.3 mM and less) is about 20%. This decrement, albeit small, is important in the overall economy of vitamin B6 metabolism and B6-dependent pathways. In a recent study (39) , growing rats that were provided 4 ,ug pyridoxine/day exhibited only a 20% decrease in liver PLP. However, these animals were vitamin B6 deficient as evidenced by retardation of growth. The liver plays a control role in vitamin B6 metabolism (40) . It actively converts pyridoxine to PLP, pyridoxal, and pyridoxic acid which are released into the circulation (41) . Whereas pyridoxic acid is biologically inactive, PLP and pyridoxal are the transport forms in plasma. Ethanol oxidation lowers hepatic PLP and impairs the release of this coenzyme (5) . As shown here, acetaldehyde also decreases hepatic PLP; however, its effect on the release of PLP and pyridoxal has not been defined.
The deleterious effect of ethanol-derived acetaldehyde on PLP metabolism may be mediated by additional mechanisms. In liver and other tissues, acetaldehyde is oxidized to acetate. Acetate has been shown to inhibit the recombination of PLP with glutamate apodecarboxylase (42) . Recently, Dietrich and Irwin (43) have suggested another effect of acetaldehyde, namely, the inhibition of the metabolic elimination of endogenous aldehydes more potent than acetaldehyde itself. These toxic endogenous aldehydes may include formaldehyde, malondialdehyde, and the biogenic aldehydes. The role of these aldehydes and acetate upon PLP binding and degradation awaits further study.
